Neuronetics gets Nasdaq deficiency notice for bid price below $1.00; 180-day cure period

Neuronetics, Inc.

Received Nasdaq letter on Oct 3, 2024; stock closed below $1.00 for 30 consecutive business days.
Must regain compliance by April 1, 2025; cure by closing at $1.00+ for 10 consecutive business days.
If not cured, may transfer to Nasdaq Capital Market for second 180-day compliance period.
Company considering available options, including a reverse stock split, to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.